OSE-127

· OSE Immunotherapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for OSE-127, covering 2025-06-22 to 2026-06-23. Get the full timeline:

Most recent: Clinical Trial Results: Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis [Phase 2]